Form4insider filings, from the source

SEC Form 3 · accession 0000200406-26-000177

JOHNSON & JOHNSON · JNJ

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Thomas Cavanaugh
Officer — EVP WW Chair, Innovative Med.
Period of report
Sep 1, 2026
Accepted (ET)
Sep 1, 2026 · 4:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000200406

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stockholding———71D
Common StockF1holding———428IBy 401k

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Options (Right to Buy)F2$243.45holding————Feb 15, 2036Common Stock15,839—D
Employee Stock Options (Right to Buy)F2$156.15holding————Feb 15, 2035Common Stock25,493—D
Employee Stock Options (Right to Buy)F2$157.92holding————Feb 15, 2034Common Stock23,311—D
Employee Stock Options (Right to Buy)F2$162.75holding————Feb 13, 2033Common Stock15,081—D
Employee Stock Options (Right to Buy)F3$165.89holding———Feb 14, 2025Feb 14, 2032Common Stock11,906—D
Employee Stock Options (Right to Buy)F3$164.62holding———Feb 8, 2024Feb 8, 2031Common Stock14,383—D
Employee Stock Options (Right to Buy)F3$151.41holding———Feb 10, 2023Feb 10, 2030Common Stock16,543—D
Restricted Share UnitsF4—holding—————Common Stock2,275—D
Restricted Share UnitsF5—holding—————Common Stock2,097—D
Restricted Share UnitsF6—holding—————Common Stock965—D

Explanation of responses